Comparison of Idraparinux With Vitamin K Antagonists for Prevention of Thromboembolism in Patients With Atrial Fibrillation - AMADEUS


The goal of this trial was to compare the safety and efficacy of idraparinux as prophylaxis against stroke and systemic embolism in patients with nonvalvular atrial fibrillation, compared with vitamin K antagonists.